Wenzhou Medical University
🇨🇳China
FDA Grants Orphan Drug Designation to China-Developed ApDC for Uveal Melanoma
An Aptamer Drug Conjugate (ApDC) developed by Chinese researchers has received orphan drug designation from the FDA for uveal melanoma treatment.